| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0519797.5AGB0519797D0 (en) | 2005-09-29 | 2005-09-29 | Therapeutic agents |
| GB0618613AGB2430621A (en) | 2005-09-29 | 2006-09-22 | Benzopyranone derivatives as antiviral agents |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0519797.5AGB0519797D0 (en) | 2005-09-29 | 2005-09-29 | Therapeutic agents |
| Publication Number | Publication Date |
|---|---|
| GB0519797D0true GB0519797D0 (en) | 2005-11-09 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0519797.5ACeasedGB0519797D0 (en) | 2005-09-29 | 2005-09-29 | Therapeutic agents |
| GB0618613AWithdrawnGB2430621A (en) | 2005-09-29 | 2006-09-22 | Benzopyranone derivatives as antiviral agents |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0618613AWithdrawnGB2430621A (en) | 2005-09-29 | 2006-09-22 | Benzopyranone derivatives as antiviral agents |
| Country | Link |
|---|---|
| GB (2) | GB0519797D0 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006119061A2 (en) | 2005-05-02 | 2006-11-09 | Merck & Co., Inc. | Hcv ns3 protease inhibitors |
| AR057456A1 (en) | 2005-07-20 | 2007-12-05 | Merck & Co Inc | HCV PROTEASA NS3 INHIBITORS |
| KR20080036598A (en) | 2005-08-01 | 2008-04-28 | 머크 앤드 캄파니 인코포레이티드 | Macrocyclic Peptides as HCV NS3 Protease Inhibitors |
| GB0609492D0 (en) | 2006-05-15 | 2006-06-21 | Angeletti P Ist Richerche Bio | Therapeutic agents |
| GB0612423D0 (en) | 2006-06-23 | 2006-08-02 | Angeletti P Ist Richerche Bio | Therapeutic agents |
| AU2007309544B2 (en) | 2006-10-24 | 2012-05-31 | Msd Italia S.R.L. | HCV NS3 protease inhibitors |
| AU2007309546A1 (en) | 2006-10-24 | 2008-05-02 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | HCV NS3 protease inhibitors |
| EP2079480B1 (en) | 2006-10-24 | 2013-06-05 | Merck Sharp & Dohme Corp. | Hcv ns3 protease inhibitors |
| ES2444575T3 (en) | 2006-10-27 | 2014-02-25 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
| WO2008057209A1 (en) | 2006-10-27 | 2008-05-15 | Merck & Co., Inc. | Hcv ns3 protease inhibitors |
| GB0625345D0 (en) | 2006-12-20 | 2007-01-31 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| CN103224506A (en) | 2006-12-20 | 2013-07-31 | P.安杰莱蒂分子生物学研究所 | Antiviral indoles |
| GB0625349D0 (en) | 2006-12-20 | 2007-01-31 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| CA2693537C (en) | 2007-07-17 | 2013-06-25 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Macrocyclic indole derivatives for the treatment of hepatitis c infections |
| WO2009010804A1 (en) | 2007-07-19 | 2009-01-22 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Macrocyclic compounds as antiviral agents |
| CA2720850A1 (en) | 2008-04-28 | 2009-11-05 | Merck Sharp & Dohme Corp. | Hcv ns3 protease inhibitors |
| CN102159285B (en) | 2008-07-22 | 2014-05-14 | 默沙东公司 | Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors |
| EP2459582B1 (en) | 2009-07-30 | 2015-05-27 | Merck Sharp & Dohme Corp. | Hepatitis c virus ns3 protease inhibitors |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6174900A (en)* | 1999-07-08 | 2001-01-30 | Patrick T. Prendergast | Use of flavones, coumarins and related compounds to treat infections |
| JP4647757B2 (en)* | 1999-08-18 | 2011-03-09 | 富山化学工業株式会社 | Chromone derivatives or salts thereof and antifungal agents containing them |
| CN100534426C (en)* | 2004-05-28 | 2009-09-02 | 养生堂有限公司 | Novel use of chromene compound |
| Publication number | Publication date |
|---|---|
| GB2430621A (en) | 2007-04-04 |
| GB0618613D0 (en) | 2006-11-01 |
| Publication | Publication Date | Title |
|---|---|---|
| EP1730148A4 (en) | Aminobenzoxazoles as therapeutic agents | |
| GB0506147D0 (en) | Therapeutic agents | |
| GB0615545D0 (en) | Therapeutic agent | |
| GB0416396D0 (en) | Therapeutic agents | |
| GB0521139D0 (en) | Therapeutic agent | |
| GB0403780D0 (en) | Therapeutic agents | |
| GB0519797D0 (en) | Therapeutic agents | |
| GB0505437D0 (en) | Therapeutic agents | |
| GB0505725D0 (en) | Therapeutic agents | |
| GB0518819D0 (en) | Therapeutic agents | |
| GB0519350D0 (en) | Therapeutic agents | |
| GB0518817D0 (en) | Therapeutic agents | |
| GB0516661D0 (en) | Therapeutic agents | |
| GB0514738D0 (en) | Therapeutic agents | |
| GB0507003D0 (en) | Therapeutic | |
| GB0518720D0 (en) | Therapeutic combination | |
| GB0501655D0 (en) | Therapeutic use | |
| GB0523998D0 (en) | Therapeutic agents | |
| GB0508153D0 (en) | Therapeutic agent | |
| GB0522433D0 (en) | Therapeutic agents | |
| GB0402918D0 (en) | Therapeutic agents | |
| GB0416934D0 (en) | Therapeutic agents | |
| GB0516787D0 (en) | Therapeutic agents | |
| GB0516496D0 (en) | Therapeutic agents | |
| GB0524968D0 (en) | Therapeutic agents |
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |